ArticleClinical case reports2026
Beyond Oral Pain: A Unique Case of Burning Mouth Syndrome With Coexisting Vulvodynia and Cognitive Impairment in a Postmenopausal Woman.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond Oral Pain: A Unique Case of Burning Mouth Syndrome With Coexisting Vulvodynia and Cognitive Impairment in a Postmenopausal Woman.Clinical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Burning mouth syndrome (BMS) is a chronic pain condition characterized by persistent intraoral burning without an identifiable cause, predominantly affecting postmenopausal women. We present a unique case of a 63-year-old Ethiopian woman exhibiting a distinctive triad of BMS, vulvodynia, and progressive cognitive decline, an association not previously documented in the literature. Symptoms progressed sequentially-oral pain first, followed by vulvar burning, and later cognitive decline-remaining resistant to multiple pharmacologic treatments. Diagnostic evaluation revealed significant cognitive impairment, particularly affecting language and executive functioning. Trials of pregabalin and vortioxetine yielded transient but modest symptom relief. Notably, the patient's cognitive deterioration appeared to fluctuate in tandem with pain severity, suggesting a possible link between symptom burden and neurocognitive function. Differential workup excluded reversible causes such as neurosyphilis, HIV, vitamin deficiencies, drug toxicities, and oral/dental pathology. This case highlights the potential neurobiological overlap between chronic pain syndromes and cognitive dysfunction and underscores the need to expand the clinical and research lens on BMS to include potential neurodegenerative components and highlights the importance of integrated, multidisciplinary care in complex chronic pain syndromes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.